JPRN-UMIN000011917已完成未知
Evaluating the safety of bevacizumab in non-squamous NSCLC patients -Observational study- - Evaluating the safety of bevacizumab in non-squamous NSCLC patients -Observational study
Division of Medical Oncology and Molecular Respirology Department of Multidisciplinary Internal Medicine Faculty of Medicine, Tottori University0 个研究点目标入组 120 人开始时间: 2013年9月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Received transfusion or G-CSF within 14 days prior to enrollment (2)Urine protein>=2+ (3)History of drug allergy (4)Active multiple cancers (5)Severe infection (6)High fever (7)Abnormal cardiac function (8)Severe pulmonary disease; Interstitial pneumonia, severe COPD, pulmonary thromboembolism (9)Need for drainage of pleural effusion, acsites or pericardial effusion (10)History of hematoemesis, ileus and gastroduodenal ulcer (11)symptomatic CNS metastases (12)CNS or Psychological disorders (13)Medically uncontrolled hypertension or diabetes mellitus (14)Nonhealing wound and surgery within 4 weeks before treatment (15)History of hemoptysis; one-half teaspoon of bright red blood per event (16)Therapeutic anticoagulation(full-dose therapeutic anticoagulation current and recent use of aspirin (>=325 mg/day) (17)severe bone marrow suppression (18)Pregnancy or lactation
研究者
相似试验
已完成
不适用
Safety assessment of treatment with bevacizumab in metastatic colorectal cancerMetastatic colorectal cancerMalignant neoplasm of rectosigmoid junctionCancerISRCTN36011949Institute of Oncology Ljubljana (Slovenia)250
进行中（未招募）
1 期
BABH Study: Efficacy and safety of bevacizumab on severe bleedings associated with Hemorrhagic Hereditary Telangiectasia (HHT)EUCTR2017-001031-39-FRHospices Civils de Lyon24
招募中
1 期
Efficacy of topical Bevacizumab in patients diagnosed with dry eye disease compared with conventional treatmentDry eye diseaseDryness of eyeeye drynessxeromaBevacizumabKeratoconjunctivitis SiccaTCTR20171024002The Asia Research Center (ARC) by Chulalongkorn University21
已完成
不适用
Evaluation of Topical Bevacizumab in TrabeculectomyGlaucoma.Glaucoma (primary)(residual stage):chronic simpleIRCT2017041433424N1Vice chancellor for research, Zahedan University of Medical Sciences20
已完成
2 期
A randomized Phase II Study of Bevacizumab in Combination with Docetaxel or S-1 in Patients with Non-Squamous Non-Small-Cell Lung Cancer Previously Treated with Platinum based Chemotherapyon-Squamous Non-Small-Cell Lung CancerJPRN-UMIN000003533Hanshin Cancer Study Group90